These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3736 related articles for article (PubMed ID: 7336169)

  • 1. ADCC of cultured human melanoma cells: analysis with monoclonal antibodies to human melanoma-associated antigens.
    Imai K; Ng AK; Glassy MC; Ferrone S
    Scand J Immunol; 1981 Oct; 14(4):369-77. PubMed ID: 7336169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.
    Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L
    Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens.
    Curry RA; Quaranta V; Pellegrino MA; Ferrone S
    Cancer Res; 1981 Feb; 41(2):463-6. PubMed ID: 7448792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon.
    Matsui M; Temponi M; Ferrone S
    J Immunol; 1987 Sep; 139(6):2088-95. PubMed ID: 3114385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies.
    Imai K; Ng AK; Glassy MC; Ferrone S
    J Immunol; 1981 Aug; 127(2):505-9. PubMed ID: 6166672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
    Plain MJ; Whitehead RH; Jose DG
    Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
    Christiaansen JE; Burnside SS; Sears DW
    J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines.
    Flieger D; Spengler U; Beier I; Kleinschmidt R; Hoff A; Varvenne M; Sauerbruch T; Schmidt-Wolf I
    Hybridoma; 1999 Feb; 18(1):63-8. PubMed ID: 10211790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity.
    Ollier J; Kervarrec T; Samimi M; Benlalam H; Aumont P; Vivien R; Touzé A; Labarrière N; Vié H; Clémenceau B
    Cancer Immunol Immunother; 2018 Aug; 67(8):1209-1219. PubMed ID: 29808366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells.
    Imai K; Wilson BS; Bigotti A; Natali PG; Ferrone S
    J Natl Cancer Inst; 1982 May; 68(5):761-9. PubMed ID: 6951087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
    Baldwin GC; Chung GY; Kaslander C; Esmail T; Reisfeld RA; Golde DW
    Br J Haematol; 1993 Apr; 83(4):545-53. PubMed ID: 7686031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
    Chen ZJ; Yang H; Ferrone S
    J Immunol; 1991 Aug; 147(3):1082-90. PubMed ID: 1861071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
    J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-dependent antibodies to antigen 3.1, a cell-surface antigen expressed by a subgroup of human melanomas.
    Hellström I; Hellström KE; Yeh MY
    Int J Cancer; 1981 Mar; 27(3):281-5. PubMed ID: 6169659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
    Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
    Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
    Herlyn D; Herlyn M; Steplewski Z; Koprowski H
    Eur J Immunol; 1979 Aug; 9(8):657-9. PubMed ID: 499332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
    J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 187.